Annual Working Capital
$274.96 M
-$49.38 M-15.22%
December 31, 2023
Summary
- As of February 7, 2025, DSGN annual working capital is $274.96 million, with the most recent change of -$49.38 million (-15.22%) on December 31, 2023.
- During the last 3 years, DSGN annual working capital has risen by +$241.06 million (+711.03%).
- DSGN annual working capital is now -27.67% below its all-time high of $380.15 million, reached on December 31, 2021.
Performance
DSGN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$249.81 M
-$8.64 M-3.34%
September 30, 2024
Summary
- As of February 7, 2025, DSGN quarterly working capital is $249.81 million, with the most recent change of -$8.64 million (-3.34%) on September 30, 2024.
- Over the past year, DSGN quarterly working capital has dropped by -$8.64 million (-3.34%).
- DSGN quarterly working capital is now -38.78% below its all-time high of $408.05 million, reached on March 31, 2021.
Performance
DSGN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
DSGN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.2% | -3.3% |
| 3 y3 years | +711.0% | -35.9% |
| 5 y5 years | +7651.8% | - |
DSGN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.7% | at low | -34.3% | at low |
| 5 y | 5-year | -27.7% | +7651.8% | -38.8% | +636.8% |
| alltime | all time | -27.7% | +7651.8% | -38.8% | +636.8% |
Design Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $249.81 M(-3.3%) |
| Jun 2024 | - | $258.45 M(-3.1%) |
| Mar 2024 | - | $266.79 M(-3.0%) |
| Dec 2023 | $274.96 M(-15.2%) | $274.96 M(-2.5%) |
| Sep 2023 | - | $282.15 M(-4.0%) |
| Jun 2023 | - | $293.91 M(-5.2%) |
| Mar 2023 | - | $309.89 M(-4.5%) |
| Dec 2022 | $324.34 M | $324.34 M(-4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $338.08 M(-4.6%) |
| Jun 2022 | - | $354.33 M(-3.8%) |
| Mar 2022 | - | $368.39 M(-3.1%) |
| Dec 2021 | $380.15 M(+1021.3%) | $380.15 M(-2.5%) |
| Sep 2021 | - | $389.79 M(-2.9%) |
| Jun 2021 | - | $401.47 M(-1.6%) |
| Mar 2021 | - | $408.05 M(+1103.6%) |
| Dec 2020 | $33.90 M(-1031.1%) | $33.90 M |
| Dec 2019 | -$3.64 M | - |
FAQ
- What is Design Therapeutics annual working capital?
- What is the all time high annual working capital for Design Therapeutics?
- What is Design Therapeutics annual working capital year-on-year change?
- What is Design Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Design Therapeutics?
- What is Design Therapeutics quarterly working capital year-on-year change?
What is Design Therapeutics annual working capital?
The current annual working capital of DSGN is $274.96 M
What is the all time high annual working capital for Design Therapeutics?
Design Therapeutics all-time high annual working capital is $380.15 M
What is Design Therapeutics annual working capital year-on-year change?
Over the past year, DSGN annual working capital has changed by -$49.38 M (-15.22%)
What is Design Therapeutics quarterly working capital?
The current quarterly working capital of DSGN is $249.81 M
What is the all time high quarterly working capital for Design Therapeutics?
Design Therapeutics all-time high quarterly working capital is $408.05 M
What is Design Therapeutics quarterly working capital year-on-year change?
Over the past year, DSGN quarterly working capital has changed by -$8.64 M (-3.34%)